| Primary |
| Product Used For Unknown Indication |
22.9% |
| Drug Use For Unknown Indication |
9.5% |
| Hypertonic Bladder |
8.9% |
| Pollakiuria |
8.4% |
| Enuresis |
6.7% |
| Bladder Spasm |
5.6% |
| Incontinence |
5.6% |
| Asthma |
4.5% |
| Bladder Disorder |
3.4% |
| Urinary Incontinence |
3.4% |
| Micturition Urgency |
2.8% |
| Blood Cholesterol Increased |
2.2% |
| Drug Exposure During Pregnancy |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hepatic Steatosis |
2.2% |
| Hypersensitivity |
2.2% |
| Hypothyroidism |
2.2% |
| Neurogenic Bladder |
2.2% |
| Stress Urinary Incontinence |
1.7% |
| Nocturia |
1.1% |
|
| Vision Blurred |
9.5% |
| Mental Status Changes |
7.9% |
| Suicidal Ideation |
7.9% |
| Vomiting |
7.9% |
| Delirium |
6.3% |
| Dry Mouth |
6.3% |
| Growth Retardation |
6.3% |
| Dizziness |
4.8% |
| Drug Ineffective |
4.8% |
| Hallucination |
4.8% |
| Tachycardia Foetal |
4.8% |
| Agitation |
3.2% |
| Alopecia |
3.2% |
| Completed Suicide |
3.2% |
| Educational Problem |
3.2% |
| Hypotension |
3.2% |
| Infection |
3.2% |
| Multiple Drug Overdose Accidental |
3.2% |
| Nausea |
3.2% |
| Platelet Count Decreased |
3.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.6% |
| Hypertonic Bladder |
13.3% |
| Product Used For Unknown Indication |
12.1% |
| Incontinence |
6.0% |
| Pollakiuria |
4.8% |
| Bladder Disorder |
4.4% |
| Asthma |
4.0% |
| Enuresis |
4.0% |
| Hypertension |
4.0% |
| Urinary Incontinence |
4.0% |
| Pain |
3.6% |
| Diabetes Mellitus |
2.8% |
| Completed Suicide |
2.4% |
| Depression |
2.4% |
| Suicide Attempt |
2.4% |
| Micturition Urgency |
2.0% |
| Urinary Tract Infection |
2.0% |
| Back Pain |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Colon Cancer |
1.6% |
|
| Dry Mouth |
11.4% |
| Completed Suicide |
8.6% |
| Suicidal Ideation |
8.6% |
| Dizziness |
7.1% |
| Vision Blurred |
7.1% |
| Respiratory Failure |
5.7% |
| Somnolence |
5.7% |
| Vomiting |
5.7% |
| Drug Ineffective |
4.3% |
| Tremor |
4.3% |
| Visual Field Defect |
4.3% |
| Weight Decreased |
4.3% |
| Accidental Overdose |
2.9% |
| Aspartate Aminotransferase Increased |
2.9% |
| Chest Discomfort |
2.9% |
| Headache |
2.9% |
| Hypersensitivity |
2.9% |
| Malaise |
2.9% |
| Nocturia |
2.9% |
| Onychoclasis |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.1% |
| Product Used For Unknown Indication |
22.0% |
| Multiple Sclerosis |
9.3% |
| Pain |
6.0% |
| Hypertension |
5.5% |
| Depression |
4.4% |
| Rheumatoid Arthritis |
3.6% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Urinary Incontinence |
2.2% |
| Diabetes Mellitus |
2.1% |
| Osteoporosis |
2.1% |
| Anxiety |
2.0% |
| Multiple Myeloma |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Insomnia |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Bladder Disorder |
1.5% |
| Hypertonic Bladder |
1.5% |
| Vitamin Supplementation |
1.5% |
|
| Weight Decreased |
12.0% |
| Urinary Tract Infection |
11.5% |
| Vomiting |
11.2% |
| Weight Increased |
6.4% |
| Vision Blurred |
5.1% |
| Nausea |
4.8% |
| Pneumonia |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Pruritus |
4.0% |
| Tremor |
4.0% |
| Pyrexia |
3.7% |
| Somnolence |
3.7% |
| Rash |
3.5% |
| Myocardial Infarction |
3.2% |
| Wheezing |
3.2% |
| Wrong Technique In Drug Usage Process |
3.2% |
| Drug Ineffective |
2.9% |
| Loss Of Consciousness |
2.9% |
| Muscular Weakness |
2.9% |
| Sepsis |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
38.5% |
| Hypertension |
7.7% |
| Anxiety |
3.8% |
| Arthritis |
3.8% |
| Blood Cholesterol |
3.8% |
| Blood Pressure |
3.8% |
| Burning Sensation |
3.8% |
| Dementia |
3.8% |
| Hypertonic Bladder |
3.8% |
| Pain |
3.8% |
| Panic Attack |
3.8% |
| Relapsing-remitting Multiple Sclerosis |
3.8% |
| Spinal Cord Disorder |
3.8% |
| Spinal Pain |
3.8% |
| Thyroid Disorder |
3.8% |
| Vein Pain |
3.8% |
|
| Palpitations |
40.0% |
| Loss Of Consciousness |
20.0% |
| Respiratory Disorder |
20.0% |
| Vision Blurred |
20.0% |
|
